Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Dihydroergotamine mesylate adverse reaction |
Causative agent (attribute) |
True |
Dihydroergotamine mesilate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dihydroergotamine mesylate allergy |
Causative agent (attribute) |
False |
Dihydroergotamine mesilate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dihydroergotamine mesylate 4mg/1mL nasal spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dihydroergotamine mesilate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dihydroergotamine mesylate 1mg/mL (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dihydroergotamine mesilate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dihydroergotamine mesylate (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dihydroergotamine mesilate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing dihydroergotamine mesylate in oral dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dihydroergotamine mesilate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely dihydroergotamine mesilate 500 microgram/1 each conventional release sublingual tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dihydroergotamine mesilate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely dihydroergotamine mesilate 1 milligram/1 each conventional release sublingual tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dihydroergotamine mesilate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dihydroergotamine mesilate 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dihydroergotamine mesilate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing dihydroergotamine mesylate in parenteral dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dihydroergotamine mesilate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing dihydroergotamine mesylate in nasal dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dihydroergotamine mesilate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing dihydroergotamine mesylate in oropharyngeal dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dihydroergotamine mesilate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dihydroergotamine mesylate allergy |
Causative agent (attribute) |
False |
Dihydroergotamine mesilate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dihydroergotamine mesilate 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dihydroergotamine mesilate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dihydroergotamine mesilate 1 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Dihydroergotamine mesilate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dihydroergotamine mesilate 1 mg oral tablet |
Has precise active ingredient |
True |
Dihydroergotamine mesilate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely dihydroergotamine mesilate 500 microgram/1 each conventional release sublingual tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Dihydroergotamine mesilate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely dihydroergotamine mesilate 500 microgram/1 each conventional release sublingual tablet (clinical drug) |
Has precise active ingredient |
True |
Dihydroergotamine mesilate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely dihydroergotamine mesilate 1 milligram/1 each conventional release sublingual tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Dihydroergotamine mesilate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely dihydroergotamine mesilate 1 milligram/1 each conventional release sublingual tablet (clinical drug) |
Has precise active ingredient |
True |
Dihydroergotamine mesilate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely dihydroergotamine mesilate 1 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Dihydroergotamine mesilate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely dihydroergotamine mesilate 1 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Dihydroergotamine mesilate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely dihydroergotamine mesilate 500 microgram/1 actuation conventional release nasal spray (clinical drug) |
Has basis of strength substance (attribute) |
True |
Dihydroergotamine mesilate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely dihydroergotamine mesilate 500 microgram/1 actuation conventional release nasal spray (clinical drug) |
Has precise active ingredient |
True |
Dihydroergotamine mesilate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |